Stockreport

Merck is said to halt acquisition talks with cancer drug developer Revolution [Seeking Alpha]

Revolution Medicines, Inc.  (RVMD) 
PDF The pharmaceutical giant had been in talks to buy the cancer drug developer in Quick Insights Merck and Revolution Medicines could not agree on valuation, which led [Read more]